Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases

International Journal of General Medicine

Volumn 2, Issue , 2009, Pages 177-182

  Zheng, Lu ^a   Luo, Guanghua ^a   Zhang, Xiaoying ^a   Zhang, Jun ^a   Zhu, Jiang ^a   Wei, Jiang ^a   Mu, Qinfeng ^a   Chen, Lujun ^a   Nilsson ehle, Peter ^b   Xu, Ning ^b  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Apolipoprotein M; Coronary artery disease; Real time PCR; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN M;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD LEVEL; BLOTTING; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77953391263     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/ijgm.s4687     Document Type: Article

References (15)

1. Visvikis-Siest S, Marteau JB. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol. 2006;17:139-151.
2. Whitney EJ, Krasuski RA, Personius BE, et al. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. Ann Intern Med. 2005;142:95-104.
3. Xu N, Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem. 1999;274:31286-31290.
4. Xie T, Rowen L, Aguado B, et al. Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res. 2003;13:2621-2636.
5. Zhang XY, Dong X, Zheng L, et al. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem. 2003;105:67-72.
6. Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med. 2005;11:418-422.
7. Hamsten A. Molecular genetics as the route to understanding, prevention, and treatment. Lancet. 1996;348(Suppl 1):S17-S19.
8. Niu N, Zhu X, Liu Y, et al. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese. Diabetes Metab Res Rev. 2007;23:21-25.
9. Jiao GQ, Yuan ZX, Xue YS, et al. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese. Clin Biochem. 2007;40:1108-1112.
10. Ahnstrom J, Axler O, Jauhiainen M, et al. Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies. J Lipid Res. 2008;49(9):1912-1917.
11. Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlback B. Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res. 2006;47:1833-1843.
12. Kabbara A, Payet N, Cottel D, Frigard B, Amouyel P, Lambert JC. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett. 2004;363:139-143.
13. Samani NJ. Molecular genetics of coronary artery disease: measuring the phenotype. Clin Sci (Lond). 1998;95:645-646.
14. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041-1046.
15. Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest. 2001;31:843-851.